Novo Nordisk , looking to turn around slowing growth of its blockbuster weight-loss drug Wegovy, plans to test whether its ...

Novo Nordisk is planning clinical trials to explore the potential of its weight-loss drugs in treating obesity-related conditions.

The Apple Watch SE 3 delivers two-day battery life, a top-of-the-line processor, an always-on display, and upgraded sensors ...

It's not as flashy as the other Apple Watches in this year's lineup, but the SE 3 will make a strong case for many buyers.

The fundamentals of the industry are driven by demographics, and broadening the scope provides a bit of growth opportunity,' ...

STORY: Novo Nordisk will test whether its future weight-loss drugs can treat a wide range of obesity-linked conditions. It’s already begun doing so with its blockbuster drug Wegovy. The Danish ...

The Apple Watch Ultra 3 is the company's longest-lasting wearable to date, but there's more to it than endurance.

Novo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, ...

Review: Subtle updates keep the Apple Watch Series 11 at the top of its game with noticeable battery gains, but the ...

A new generation of Alzheimer’s blood tests could speed up diagnosis and access to care—but they also raise thorny questions ...